Hospital Son Llatzer   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Palma de Mallorca Spain (2001)

Organization Overview

First Clinical Trial
2004
NCT02209974
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital Son Llatzer | Hospital Son Llátzer | Hospital Son Llatzer de Mallorca | Hospital Son Llàtzer

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alkalosis (Phase 3)

Anus Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Chronic Disease (Phase 3)

Colorectal Neoplasms (Phase 2)

HIV Infections (Phase 3)

Hypoventilation (Phase 3)

Infections (Phase 3)

Inflammation (Phase 4)

Intervertebral Disc Displacement (Phase 2)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Obesity Hypoventilation Syndrome (Phase 3)

Ovarian Neoplasms (Phase 2)

Pseudomonas Infections (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 23